AMZN
Amazon.com, Inc.
AMZN has the edge over HBB overall, supported by stronger modeled upside and lower modeled downside.
HBB
Hamilton Beach Brands Holding Company
HBB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
HBB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
HBB's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over HBB in the historical PE scenario, which offers more potential upside but is not a forecast.
HBB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.2x | $27.09 | -11% |
| Current | 7x | $30.50 | — |
| Fair | 9.1x | $40.03 | +31% |
| Expensive | 13x | $56.43 | +85% |
Historical ranges are pointers, not guarantees.
HBB's PE is in its cheap range at 7.0x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
HBB Forward outlook
There aren't enough analyst estimates for HBB to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over HBB on earnings, with more consistent year-over-year improvement.
HBB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $4.38 | +90% |
| Q2 2026 | $4.24 | +83% |
| Q1 2026 | $2.08 | -14% |
| Q4 2025 | $1.95 | -11% |
| Q3 2025 | $2.30 | +23% |
| Q2 2025 | $2.32 | -6.1% |
| Q1 2025 | $2.41 | +17% |
| Q4 2024 | $2.20 | +22% |
HBB earned $4.38 per share over the past year, up 90% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over HBB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over HBB on profitability, with a higher operating margin.
HBB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $140.3M | +5.6% |
| Q2 2026 | $142.6M | +12% |
| Q1 2026 | $122M | -8.6% |
| Q4 2025 | $212.9M | -0.3% |
| Q3 2025 | $132.8M | -15% |
| Q2 2025 | $127.8M | -18% |
| Q1 2025 | $133.4M | +4% |
| Q4 2024 | $213.5M | +3.3% |
HBB's revenue is recovering but still below its 2020 peak: $140M last quarter, up 5.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.1% | +1 points |
| Q2 2026 | 30% | +26 points |
| Q1 2026 | 4.1% | +2.3 points |
| Q4 2025 | 12% | +0.9 points |
| Q3 2025 | 2.2% | -4.6 points |
| Q2 2025 | 4.7% | -1.7 points |
| Q1 2025 | 1.7% | +2.5 points |
| Q4 2024 | 11% | -1.1 points |
HBB's operating margin was 3.1% last quarter, up 1 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
HBB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6M | +123% |
| Q1 2026 | $3M | -51% |
| Q4 2025 | $27.9M | -5.1% |
| Q3 2025 | $8.4M | +$11.1M |
| Q1 2025 | $6.1M | -67% |
| Q4 2024 | $29.4M | +56% |
| Q3 2024 | -$2.7M | -125% |
| Q2 2024 | $16.8M | -21% |
HBB has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
HBB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -56K shares |
| 1 year | -0.4% | -52K shares |
| 3 years | -4.2% | -594K shares |
| 5 years | -3.2% | -446K shares |
| Available history | -1.2% | -169K shares |
HBB has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $562,000 |
| Q2 2026 | $2M |
| Q1 2026 | $1.2M |
| Q4 2025 | $1.1M |
| Q3 2025 | $575,000 |
| Q1 2025 | $3.4M |
| Q4 2024 | $4.2M |
| Q3 2024 | $5.3M |
HBB spent $5M buying back its own shares over the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
HBB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.6x | Net Cash |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | 0.6x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.5x | Very low |
| Q4 2023 | 0.9x | Very low |
HBB has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
HBB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.7 | Neutral |
| Stochastic | 41.0 | Neutral |
HBB's weekly RSI is 55 (neutral) and its Stochastic is 41 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
HBB PE vs Consumer Cyclical Sector
| Metric | HBB | Sector median | Relative |
|---|---|---|---|
| PE | 7x | 18x | 61% below |
| PE % | 26 | 47 | 21 pts below |
HBB has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over HBB on trend strength, trading above more of its moving averages.
HBB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.0 | 10% below |
| 20 week MA | $30.3 | 0.6% above |
| 50 week MA | $23.4 | 31% above |
| 100 week MA | $20.0 | 53% above |
| 200 week MA | $18.5 | 65% above |
HBB's trend is up, with a small recent dip: it's below only its 8-week average, and 65% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
HBB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.0 | $17.2 | -9.7% |
| 2021 | $17.2 | $13.9 | -19% |
| 2022 | $13.9 | $13.9 | +0.3% |
| 2023 | $13.9 | $17.5 | +26% |
| 2024 | $17.5 | $16.8 | -4.1% |
| 2025 | $16.8 | $16.2 | -3.3% |
| 2026 YTD | $16.2 | $30.5 | +88% |
HBB has the edge over AMZN on returns for 2026, with the stronger performance.